Sea Ltd’s Dermatology Deal: Big Rewards, Big Risks in an Expanding Market
Sea Ltd’s new small‑molecule dermatology partnership offers milestone cash, rapid regulatory pathways and a $5–$8 bn market upside, but high attrition, IP and supply‑chain risks remain critical.
5 minutes to read









